PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-000876-PIP05-15-M05
Compliance opinion date
Compliance outcome
Positive
Decision
P/0074/2022 : EMA decision of 11 March 2022 on the acceptance of a modification of an agreed paediatric investigation plan for eculizumab (Soliris), (EMEA-000876-PIP05-15-M05)